Chinook and Ionis partner to develop ASO therapy for kidney disease
Pharmaceutical Technology
MAY 17, 2023
Antisense therapies are designed for destroying mRNA, reducing the amount of disease-causing protein. They will also have the potential to treat diseases that are caused by too little protein by increasing production, thus restoring the protein to normal levels.
Let's personalize your content